查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679389

乳糜泻治疗市场规模、份额、趋势分析报告：按疗法、分销管道、地区和细分市场预测，2025 年至 2030 年

Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten Degrading Enzymes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

乳糜泻治疗市场趋势

预计 2024 年全球乳糜泻治疗市场规模将达到 6.902 亿美元，2025 年至 2030 年的复合年增长率为 11.7%。

其中最主要的是全球乳糜泻的盛行率不断上升。最近的估计表明，大约每 100 个美国人中就有 1 人患有乳糜泻，但很大一部分人仍未被诊断出来。确诊病例的增加是由于人们认识的提高和诊断能力的提高，这直接转化为对有效治疗方法和诊断方法的需求增加。乳糜泻市场受益于患者数量的不断增长，推动了药物创新并扩大了对专业饮食管理的需求。

随着大众对乳糜泻症状和早期诊断重要性的认识不断提高，越来越多的患者愿意寻求医疗治疗和检测，这有助于确诊病例。 Beyond Celiac 在 2023 年进行的一项调查显示，只有大约 50% 的美国人知道乳糜泻或麸质敏感性。然而，不断扩张的无麸质食品产业为患有乳糜泻的人们提供了多种饮食选择。此类产品的供应对于确保患者遵守饮食限制起着关键作用，从而改善患者健康状况并促进市场成长。

改进的检测方法，例如就地检验（POCT）的进步，正在促进早期发现和干预，从而实现更快、更有效的治疗。许多国家的政府倡议，例如针对高风险族群的筛检计划，进一步支持了市场发展。这些积极措施将增加确诊病例的数量，并为患者提供及时的诊断和治疗选择，促进更全面、更积极主动的医疗保健方法。值得注意的是，各国正在实施一项计划，提高人们对乳糜泻的认识，改善诊断和治疗的机会，强调解决这一日益严重的健康问题的努力。

新治疗方法的研究和开发有望在未来几年为乳糜泻的治疗带来新的发展。抗发炎药物和治疗性疫苗的开发有望增加治疗选择并扩大市场机会。此外，医疗保健支出的增加和研发活动的活性化（特别是新治疗方法的研发活动）预计将推动市场扩张。主要企业正在增加对药品和无麸质产品的投资，表明他们专注于改善患者健康、提高市场渗透率和满足不断增长的消费者群体。

目录

第一章调查方法与范围

第二章执行摘要

3. 乳糜泻治疗市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析

4. 乳糜泻治疗市场：治疗业务分析

  • 2024年和2030年的治疗市场占有率
  • 治疗细分仪表板
  • 2018 年至 2030 年按治疗类型分類的市场规模、预测和趋势分析
  • 维生素和矿物质
  • 麸质降解酶
  • 治疗（抗发炎药、抗组织胺等）
  • 其他的

5. 乳糜泻治疗市场：通路业务分析

  • 2024年及2030年分销通路市场占有率
  • 分销通路细分仪表板
  • 2018 年至 2030 年按分销管道分類的市场规模、预测和趋势分析
  • 医院药房
  • 零售药局
  • 其他的

第六章 乳糜泻治疗市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 2018-2030年各国情况
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年各国情况
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 2018-2030年各国情况
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030年各国情况
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年各国情况
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Teva Pharmaceutical Industries Ltd.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC.
    • GLENMARK PHARMACEUTICALS LTD.
    • Takeda Pharmaceutical Company Limited
    • Hikma Pharmaceuticals PLC
    • Viatris Inc.
    • Zydus Pharmaceuticals, Inc.
    • Novartis Pharmaceuticals Corporation
    • BioLineRx
Product Code: GVR-4-68040-488-7

Celiac Disease Treatment Market Trends:

The global celiac disease treatment market size was estimated at USD 690.2 million in 2024 and is projected to grow at a CAGR of 11.7% from 2025 to 2030. Foremost among these is the escalating prevalence of diagnosed celiac disease cases globally. According to recent estimates, approximately 1 in 100 Americans suffers from celiac disease, although a significant proportion of cases remain undiagnosed. This rise in diagnosed instances, attributed to increased awareness and improved diagnostic capabilities, directly translates into a greater demand for effective treatments and diagnostic methodologies. The market benefits from this increasing patient base, driving pharmaceutical innovation and expanding the need for specialized dietary management.

As public knowledge about celiac disease symptoms and the crucial role of early diagnosis continues to grow, individuals are increasingly proactively seeking medical consultations and testing, thereby contributing to the increased identification of cases. Notably, a 2023 survey by Beyond Celiac revealed that only approximately 50% of Americans know anything about celiac disease or gluten sensitivity, indicating a growing awareness gap that needs to be bridged. However, the expanding gluten-free food industry offers a diverse range of dietary options for individuals managing the disease. The availability of these products plays a significant role in patient adherence to dietary restrictions, thereby improving health outcomes and contributing to market growth.

Improvements in detection methods, such as advancements in point-of-care testing (POCT), have facilitated earlier identification and intervention, leading to quicker and more effective treatment. Government initiatives across numerous nations, including screening programs targeting high-risk demographics, further bolster market development. These proactive measures increase the number of diagnosed cases and provide patients with timely access to diagnostics and treatment options, thereby promoting a more comprehensive and proactive healthcare approach. Notably, various countries have implemented programs to raise awareness about celiac disease and enhance access to diagnostics and treatment, underscoring the commitment to addressing this growing health concern.

Ongoing research into new therapeutic modalities assures novel developments in the treatment of celiac disease in the coming years. The development of anti-inflammatory drugs and therapeutic vaccines is expected to enhance treatment options and expand market opportunities. Furthermore, increasing healthcare expenditure and robust R&D activities, particularly in novel treatment alternatives, are poised to drive market expansion. Key players are increasingly investing in drugs and gluten-free products, indicating an emphasis on improving patient health, driving market penetration, and catering to an expanding consumer base.

Global Celiac Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global celiac disease treatment market report based on treatment, distribution channel, and region:

  • Treatment Outlook (Revenue, USD Million, 2018 - 2030)
  • Vitamins & Minerals
  • Gluten Degrading Enzymes
  • Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
  • Other Treatments
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Celiac Disease Treatment Market: Treatment Business Analysis

  • 4.1. Treatment Market Share, 2024 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Vitamins & Minerals
    • 4.4.1. Vitamins & Minerals Market, 2018 - 2030 (USD Million)
  • 4.5. Gluten Degrading Enzymes
    • 4.5.1. Gluten Degrading Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
    • 4.6.1. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others) Market, 2018 - 2030 (USD Million)
  • 4.7. Other Treatments
    • 4.7.1. Other Treatments Market, 2018 - 2030 (USD Million)

Chapter 5. Celiac Disease Treatment Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.6. Other Distribution Channels
    • 5.6.1. Other Distribution Channels Market, 2018 - 2030 (USD Million)

Chapter 6. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Teva Pharmaceutical Industries Ltd.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Amgen Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Amneal Pharmaceuticals LLC.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. GLENMARK PHARMACEUTICALS LTD.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Takeda Pharmaceutical Company Limited
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Hikma Pharmaceuticals PLC
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Viatris Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Zydus Pharmaceuticals, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Novartis Pharmaceuticals Corporation
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. BioLineRx
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global celiac disease treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 Global celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 North America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 U.S. Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 Canada celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 14 Mexico celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Europe celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 UK Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Germany celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Germany celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 France Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Italy celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Italy celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Spain celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Spain celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Norway celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Denmark celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Denmark celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Sweden celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 33 Sweden celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Japan celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Japan celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 China celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 China celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 India celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 India celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Australia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Australia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 South Korea celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 46 South Korea celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Thailand celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 48 Thailand celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Latin America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Latin America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Brazil celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 53 Brazil celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Argentina celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 55 Argentina celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 South Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 South Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63 UAE celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 64 UAE celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Kuwait celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 66 Kuwait celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Celiac disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment and distribution channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Celiac disease treatment market dynamics
  • Fig. 12 Celiac disease treatment market: Porter's five forces analysis
  • Fig. 13 Celiac disease treatment market: PESTLE analysis
  • Fig. 14 Celiac disease treatment market: Treatment segment dashboard
  • Fig. 15 Celiac disease treatment market: Treatment market share analysis, 2024 & 2030
  • Fig. 16 Vitamins & minerals market, 2018 - 2030 (USD Million)
  • Fig. 17 Gluten degrading enzymes market, 2018 - 2030 (USD Million)
  • Fig. 18 Symptomatic treatment (anti-inflammatory drugs, antihistamines, others) market, 2018 - 2030 (USD Million)
  • Fig. 19 Other treatments market, 2018 - 2030 (USD Million)
  • Fig. 20 Celiac disease treatment market: Distribution channel segment dashboard
  • Fig. 21 Celiac disease treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 22 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 23 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 24 Other distribution channels market, 2018 - 2030 (USD Million)
  • Fig. 25 Celiac disease treatment market revenue, by region
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. country dynamics
  • Fig. 30 U.S. celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada country dynamics
  • Fig. 32 Canada celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico country dynamics
  • Fig. 34 Mexico celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 UK country dynamics
  • Fig. 37 UK celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany country dynamics
  • Fig. 39 Germany celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 France country dynamics
  • Fig. 41 France celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy country dynamics
  • Fig. 43 Italy celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain country dynamics
  • Fig. 45 Spain celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway country dynamics
  • Fig. 47 Norway celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia country dynamics
  • Fig. 60 Australia celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand country dynamics
  • Fig. 64 Thailand celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil country dynamics
  • Fig. 67 Brazil celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 MEA celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait country dynamics
  • Fig. 78 Kuwait celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 79 Company categorization
  • Fig. 80 Company market position analysis
  • Fig. 81 Strategic framework